Clinical trial
The Third, Intensive Care Bundle With Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial
NCT03209258
Study timeline
Study start (actual)2017-12-12Date precision: day
Registry last updated2022-11-29
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Cerebral Hemorrhageunresolved
Strokeunresolved
Hypertensionunresolved
Diabetesunresolved
Anticoagulant-induced Bleedingunresolved
Cerebral Vascular Disorderunresolved
Brain Disorderunresolved
Hemorrhageunresolved
Intracranial Hemorrhagesunresolved
Cardiovascular Diseasesunresolved
Central Nervous System Diseasesunresolved
Interventions
Sponsors & collaborators
The George Institute for Global Health, Chinalead sponsor
West China Hospitalcollaborator
Sichuan Credit Pharmaceutical Co., Ltd.collaborator
Takedacollaborator
UK Research and Innovationcollaborator
Medical Research Councilcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03209258 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.